1,802
Views
1
CrossRef citations to date
0
Altmetric
Article

Glucose intolerance in intensive care patients: Incidence and outcome

, , &
Pages 28-34 | Received 17 Nov 2020, Accepted 10 Dec 2020, Published online: 23 Dec 2020

References

  • Kowalski GM, Bruce CR. The regulation of glucose metabolism: implications and considerations for the assessment of glucose homeostasis in rodents. Am J Physio Endocrinol Metab. 2014;307(10):E859–E871.
  • Pillot B, Soty M, Gautier-Stein A, et al. Protein feeding promotes redistribution of endogenous glucose production to the kidney and potentiates its suppression by insulin. Endocrinology. 2009;150(2):616–624..
  • Dombrowski NC, Karounos DG. Pathophysiology and management strategies for hyperglycemia for patients with acute illness during and following a hospital stay. Metabolism. 2013;62(3):326–336.
  • Deane AM, Horowitz M. Dysglycaemia in the critically ill: significance and management. Diabetes Obes Metab. 2013;15(9):792–801.
  • Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–1131.
  • Ş T, Yüksel RC, Gündoğan K. et al. Stress hyperglycemia incidence in critically ill patients: cross-sectional observational study. Yoğun Bakım Derg. 2018;9(2):46–50.
  • Lacherade JC, Jacqueminet S, Preiser JC. An overview of hypoglycemia in the critically ill. J Diabetes Sci Technol. 2009;3(6):1242–1249.
  • Godinjak A, Iglica A, Burekovic A, et al. Hyperglycemia in critically ill patients: management and prognosis. Med Arch. 2015;69(3):157–160.
  • Casillas S, Jauregui E, Surani S, et al. Blood glucose control in the intensive care unit: where is the data? World J Meta-Anal. 2019;7(8):399–405.
  • Cely CM, Arora P, Quartin AA, et al. Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest. 2004;126(3):879–887.
  • Donihi AC, Raval D, Saul M, et al. A. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract. 2006;12(4):358–362.
  • Phadke D, Beller JP, Tribble C. The disparate effects of epinephrine and norepinephrine on hyperglycemia in cardiovascular surgery. Heart Surg Forum. 2018;21(6):E522–E526.
  • Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response. Crit Care. 2013;17(2):305.
  • De La Rosa Gdel C, Donado JH, Restrepo AH, et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care. 2008;12(5):R120.
  • Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008 Aug 27;300(8):933–944.
  • Brunkhorst FM, Engel C, Bloos F, et al. German competence network sepsis (SepNet) intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125–139.
  • Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35(10):1738–1748.
  • The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–1297.
  • Griesdale DE, De Souza RJ, Van Dam RM. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821–827.
  • Green JP, Berger T, Garg N, et al. Hyperlactatemia affects the association of hyperglycemia with mortality in non-diabetic adults with sepsis. Acad Emerg Med. 2012;19(11):1268–1275.
  • Tiruvoipati R, Chiezey B, Lewis D, et al. Stress hyperglycemia may not be harmful in critically ill patients with sepsis. J Crit Care. 2012;27(2):153–158.
  • Cichosz SL, Schaarup C. Hyperglycemia as a predictor for adverse outcome in ICU patients with and without diabetes. J Diabetes Sci Technol. 2017;11(6):1272–1273.
  • Deedwania P, Kosiborod M, Barrett E, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association diabetes committee of the council on nutrition, physical activity, and metabolism. Circulation. 2008;117(12):1610–1619.
  • Goyal A, Mahaffey KW, Garg J, et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J. 2006;27(11):1289–1297.
  • Kosiborod M, Inzucchi SE, Krumholz HM, et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation. 2008 Feb 26;117(8):1018–1027.
  • Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005 Jun 14;111(23):3078–3086.
  • Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000 Mar 4;355(9206):773–778.
  • Callahan LA, Supinski GS. Hyperglycemia-induced diaphragm weakness is mediated by oxidative stress. Crit Care. 2014;18(3):R88.
  • Becker CD, Sabang RL, Nogueira Cordeiro MF, et al. Hyperglycemia in medically critically ill patients: risk factors and clinical outcomes. Am J Med. 2020 Oct;133(10):e568–e574.